Get the content you want anytime you want.
REGISTER NOW | SIGN IN

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HEALTHCARE-ASSOCIATED INFECTIONS (HAI) NEWS - Page 1

Can Fidaxomicin Provide Effective <i>C difficile</i>-Associated Diarrhea Prophylaxis for HSCT Recipients?
Clostridium difficile rates in stem cell transplant patients are approximately 9 times greater than in hospitalized patients, with rates about twice as high in allogeneic vs autologous transplants.
Are We Taking a Step Back in Staph?
Staph infections aren't going away and now a new report says we're not doing as well as we think.
Combination Therapy Key to Treating Invasive <i>Candida auris</i> Infections
It’s become a serious global health threat, and now a new study investigating 9 cases of Candida auris infections in Brooklyn highlights the importance of quickly identifying these fungal infections.
Can HAI Reporting Limit Infection Prevention Presence?
State health care-associated infection reporting laws are critical for surveillance, but are they bogging down infection prevention programs?
Workplace Infection Risks Evolving, Employers Struggle to Keep Up
Workers in a variety of industries—not just health care—face significant risk of infection at work. A new study finds a number of new risks are emerging, adding to the need for vigilance.
Valganciclovir Preferred to Prevent Cytomegalovirus After Allogeneic Hematopoietic Cell Transplantation
Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.
The Longer the Scrub, the Cleaner the Hub
The length of mechanical friction applied to the needleless connector of a central venous catheter before insertion may make a difference in rate of disinfection.
No Relevant Pharmacokinetic Interactions Between Rezafungin and Commonly Co-administered Drugs
Investigators detected no relevant change in systemic concentrations of 9 probe drugs when rezafungin was dosed concomitantly.
FEATURED
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.